Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(2E)-2-(4-hydroxy-3-methoxybenzylidene)-3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
-
(2E)-2-(4-hydroxy-3-methoxybenzylidene)-3-oxo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]butanamide
-
(2E)-2-(4-hydroxy-3-methoxybenzylidene)-3-oxo-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]butanamide
-
(2E)-2-(4-hydroxybenzylidene)-3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
-
(2E)-2-(4-hydroxybenzylidene)-3-oxo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]butanamide
-
(2E)-2-(4-hydroxybenzylidene)-3-oxo-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]butanamide
-
(6R,7S)-6-(acetyloxy)-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl (2Z)-2-methylbut-2-enoate
mixed-type inhibition
(6R,7S)-6-hydroxy-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl (2E)-2-methylbut-2-enoate
mixed-type inhibition
(6R,7S)-6-hydroxy-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl 3-methylbut-2-enoate
noncompetitive inhibition
(6R,7S)-6-methoxy-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl 3-methylbut-2-enoate
noncompetitive inhibition
(6R,7S)-7-hydroxy-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-yl 4-methylpent-3-enoate
mixed-type inhibition
(dibutyl phosphoric) hypochlorous anhydride
-
1,2,2-triethyl-2,3-dihydro-1H-quinazolin-4-one
-
1,2,3,4-tetrahydroacridin-9-amine
-
1,2-diethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(2-chloro-benzyl)-2,2-diethyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(2-chloro-benzyl)-2,2-diisobutyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(2-chloro-benzyl)-2,2-dimethyl-2,3-dihydro-1Hquinazolin-4-one
-
1-(2-chloro-benzyl)-2-(4-chloro-phenyl)-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(2-chloro-benzyl)-2-ethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(2-chloro-benzyl)-2-isobutyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(2-chloro-benzyl)-2-methyl-2-phenyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(2-chloro-benzyl)-2-methyl-2-propyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(2-fluorobenzyl)-N-[6-(1H-indol-1-yl)hexyl]piperidin-4-amine
-
1-(2-fluorobenzyl)-N-[8-(1H-indol-1-yl)octyl]piperidin-4-amine
-
1-(3-chlorobenzyl)-N-[6-(1H-indol-1-yl)hexyl]piperidin-4-amine
-
1-(3-chlorobenzyl)-N-[8-(1H-indol-1-yl)octyl]piperidin-4-amine
-
1-(4-chloro-benzyl)-2,2-diethyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(4-chloro-benzyl)-2,2-diisobutyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(4-chloro-benzyl)-2-(4-chloro-phenyl)-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(4-chloro-benzyl)-2-ethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(4-chloro-benzyl)-2-isobutyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(4-chloro-benzyl)-2-methyl-2-phenyl-2,3-dihydro-1H-quinazolin-4-one
-
1-(4-chloro-benzyl)-2-methyl-2-propyl-2,3-dihydro-1H-quinazolin-4-one
-
1--(4-chloro-benzyl)-2,2-dimethyl-2,3-dihydro-1H-quinazolin-4-one
-
1-benzyl-2,2-diethyl-2,3-dihydro-1H-quinazolin-4-one
-
1-benzyl-2,2-diisobutyl-2,3-dihydro-1Hquinazolin-4-one
-
1-benzyl-2,2-dimethyl-2,3-dihydro-1H-quinazolin-4-one
-
1-benzyl-2-(4-chloro-phenyl)-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-benzyl-2-ethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-benzyl-2-isobutyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-benzyl-2-methyl-2-phenyl-2,3-dihydro-1H-quinazolin-4-one
-
1-benzyl-2-methyl-2-propyl-2,3-dihydro-1H-quinazolin-4-one
-
1-benzyl-N-[3-(2,3-dihydro-1H-indol-1-yl)propyl]piperidin-4-amine
-
1-benzyl-N-[5-(2,3-dihydro-1H-indol-1-yl)pentyl]piperidin-4-amine
-
1-benzyl-N-[6-(1H-indol-1-yl)hexyl]piperidin-4-amine
-
1-benzyl-N-[8-(1H-indol-1-yl)octyl]piperidin-4-amine
-
1-ethyl-2,2-diisobutyl-2,3-dihydro-1H-quinazolin-4-one
-
1-ethyl-2,2-dimethyl-2,3-dihydro-1H-quinazolin-4-one
-
1-ethyl-2-isobutyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
1-ethyl-2-methyl-2-phenyl-2,3-dihydro-1H-quinazolin-4-one
-
1-ethyl-2-methyl-2-propyl -2,3-dihydro-1H-quinazolin-4-one
-
2,3-dihydroquinazolin-4(1H)-one
-
2-(3-[[1-(2-fluorobenzyl)piperidin-4-yl]amino]propyl)-1H-isoindole-1,3(2H)-dione
-
2-(3-[[1-(3-chlorobenzyl)piperidin-4-yl]amino]propyl)-1H-isoindole-1,3(2H)-dione
-
2-(3-[[1-(4-hydroxybenzyl)piperidin-4-yl]amino]propyl)-1H-isoindole-1,3(2H)-dione
-
2-(3-[[1-(4-methoxybenzyl)piperidin-4-yl]amino]propyl)-1H-isoindole-1,3(2H)-dione
-
2-(4-chloro-phenyl)-1-ethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
-
2-(4-hydroxy-3-methoxybenzyl)-3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
-
2-(4-hydroxy-3-methoxybenzyl)-3-oxo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]butanamide
-
2-(4-hydroxy-3-methoxybenzyl)-3-oxo-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]butanamide
neuroprotective effect of K3-2 against H2O2-induced toxicity
2-(4-hydroxybenzyl)-3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
-
2-(4-hydroxybenzyl)-3-oxo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]butanamide
-
2-(4-hydroxybenzyl)-3-oxo-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]butanamide
-
2-(6-[[1-(2-fluorobenzyl)piperidin-4-yl]amino]hexyl)-1H-isoindole-1,3(2H)-dione
-
2-(6-[[1-(3-chlorobenzyl)piperidin-4-yl]amino]hexyl)-1H-isoindole-1,3(2H)-dione
-
2-(6-[[1-(4-hydroxybenzyl)piperidin-4-yl]amino]hexyl)-1H-isoindole-1,3(2H)-dione
-
2-(6-[[1-(4-methoxybenzyl)piperidin-4-yl]amino]hexyl)-1H-isoindole-1,3(2H)-dione
-
2-(8-[[1-(2-fluorobenzyl)piperidin-4-yl]amino]octyl)-1H-isoindole-1,3(2H)-dione
-
2-(8-[[1-(3-chlorobenzyl)piperidin-4-yl]amino]octyl)-1H-isoindole-1,3(2H)-dione
a selective BChE inhibitor
2-(8-[[1-(4-hydroxybenzyl)piperidin-4-yl]amino]octyl)-1H-isoindole-1,3(2H)-dione
-
2-(8-[[1-(4-methoxybenzyl)piperidin-4-yl]amino]octyl)-1H-isoindole-1,3(2H)-dione
-
2-amino-3-((1R)-1-cyclohexyl-2-[(cyclohexylcarbonyl)amino]ethyl)-6-phenoxyquinazolin-3-ium
-
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one
-
2-[(5-acetyl-6-methyl-4-phenyl-1,4-dihydropyrimidin-2-yl)sulfanyl]-N-phenylacetamide
-
2-[3-[(1-benzylpiperidin-4-yl)amino]propyl]-1H-isoindole-1,3(2H)-dione
-
2-[5-[(1-benzylpiperidin-4-yl)amino]pentyl]-1H-isoindole-1,3(2H)-dione
-
2-[6-[(1-benzylpiperidin-4-yl)amino]hexyl]-1H-isoindole-1,3(2H)-dione
-
2-[8-[(1-benzylpiperidin-4-yl)amino]octyl]-1H-isoindole-1,3(2H)-dione
-
2-[[5-acetyl-6-methyl-4-(4-phenoxyphenyl)-1,4-dihydropyrimidin-2-yl]sulfanyl]-N-phenylacetamide
-
3,5,7,3',4'-pentamethoxyflavone
-
3-oxo-N-[(1,2,3,4-tetrahydroacridin-9-ylamino)methyl]butanamide
-
3-oxo-N-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]butanamide
-
3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
-
3-oxo-N-[5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]butanamide
-
3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
-
4-[(4-[[6-(1H-indol-1-yl)hexyl]amino]piperidin-1-yl)methyl]phenol
-
4-[(4-[[8-(1H-indol-1-yl)octyl]amino]piperidin-1-yl)methyl]phenol
-
6,8-dibromo-2-(4-chlorophenyl)-2-methyl-2,3-dihydroquinazolin-4(1H)-one
-
6-formylumbelliferone
isolated from Angelica decursiva, noncompetitive inhibition
8-formylumbelliferone
noncompetitive inhibition
benzyl di-n-butyl phosphate
-
butyl ethyl phenyl phosphate
-
decursidin
competitive inhibition
di-n-butyl 2-chlorophenyl phosphate
irreversible inhibition
di-n-butyl 2-methylbenzyl phosphate
-
di-n-butyl 2-methylphenyl phosphate
reversible inhibition
di-n-butyl 2-naphthyl phosphate
-
di-n-butyl 2-phenylethyl phosphate
-
di-n-butyl 3,4,5-trimethylphenyl phosphate
-
di-n-butyl 3,4-dimethylphenyl phosphate
-
di-n-butyl 3,5-dimethylphenyl phosphate
-
di-n-butyl 3-methylbenzyl phosphate
-
di-n-butyl 3-methylphenyl phosphate
reversible inhibition
di-n-butyl 4-methylbenzyl phosphate
-
di-n-butyl 4-methylphenyl phosphate
reversible inhibition
di-n-butyl naphthalen-1-yl phosphate
-
di-n-butyl phenyl phosphate
-
di-n-pentyl phenyl phosphate
-
dicyclohexyl phenyl phosphate
-
diethyl 2-naphthyl phosphate
-
diethyl 3,5-dimethylphenyl phosphate
-
diethyl phenyl phosphate
-
dimethyl phenyl phosphate
-
N,N-di-sec-butyl-2-(1,3-dioxoisoindolin-2-yl)acetamide
-
N,N-dibutyl-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetamide
-
N,N-dicyclohexyl-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetamide
-
N-(cyclohexyl)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-methylacetamide
-
N-[4-[4-(1,3-benzothiazol-2-yl)phenoxy]butyl]-6-chloro-1,2,3,4-tetrahydroacridin-9-amine
-
N-[6-(1H-indol-1-yl)hexyl]-1-(4-methoxybenzyl)piperidin-4-amine
-
N-[8-(1H-indol-1-yl)octyl]-1-(4-methoxybenzyl)piperidin-4-amine
-
O-ethyl-S-2-diisopropylaminoethylmethylphosphonothiolate
-
phenyl dipropyl phosphate
-
R-DEPP
O,R-diethylphenylphosphonothioate, stereospecific inhibition kinetics and stereospecificity of the chiral nerve agent derivative O,R-diethylphenylphosphonothioate. Chemical modification by DEPP, a measurable amount of the enzyme-phosphonate adduct does not undergo aging
S-DEPP
O,S-diethylphenylphosphonothioate, stereospecific inhibition kinetics and stereospecificity of the chiral nerve agent derivative O,S-diethylphenylphosphonothioate. Chemical modification by DEPP, a measurable amount of the enzyme-phosphonate adduct does not undergo aging. Pralidoxime, a common rescue agent, affects a modest recovery of eqBChE from treatment with S-DEPP. S-DEPP inhibition is practically irreversible. Kinetic analysis of S-DEPP with cholinesterases
tacrine-caffeic acid hybrid
-
umbelliferone
isolated from Angelica decursiva
(+)-7-deoxy-O6-buxafurandiene
-
isolated from Buxus hyrcana
(+)-benzoylbuxidienine
-
isolated from Buxus hyrcana
(+)-buxapapillinine
-
isolated from Buxus hyrcana
(+)-buxaquamarine
-
isolated from Buxus hyrcana
(+)-irehine
-
isolated from Buxus hyrcana
(+)-limonene
-
identified compound of Pimpinella anisodes, IC50: 456.2 microgram/ml
(+)-O6-buxafurandiene
-
isolated from Buxus hyrcana
(+)-sabinene
-
identified compound of Pimpinella anisodes, IC50: 218.6 microgram/ml
(-)-10,10-dimethylhuperzine A
-
-
(-)-3-O-acetyl-spectaline
-
isolated from flowers of Senna spectabilis
(-)-Carvone
-
62.4% inhibition at 1 mM
(-)-galanthamine
-
isolated from Galanthus woronowii
(-)-spectaline
-
isolated from flowers of Senna spectabilis
(13E,13'Z)-N,N'-hexane-1,6-diylbis(6,7,8,9,10,11-hexahydro-13H-azocino[2,1-b]quinazolin-13-imine)
-
-
(13Z,13'Z)-N,N'-heptane-1,7-diylbis(6,7,8,9,10,11-hexahydro-13H-azocino[2,1-b]quinazolin-13-imine)
-
-
(1alpha,3beta,22R)-stigmast-5-ene-1,3,22-triol
-
i.e. haloxysterol A, isolated from Haloxylon recurvum
(1alpha,3beta,22R)-stigmasta-4,6-diene-1,3,22-triol
-
i.e. haloxysterol B, isolated from Haloxylon recurvum
(1alpha,3beta,5alpha,6beta,22R)-stigmastane-1,3,5,6,22-pentol
-
i.e. haloxysterol D, isolated from Haloxylon recurvum
(1S,2S,11bS)-4-[2-(acetyloxy)ethyl]-5-methyl-1,2,3,4,4a,5,6,11b-octahydro[1,3]dioxolo[4,5-j]phenanthridine-1,2-diyl diacetate
-
-
(1S,2S,11bS)-4-[2-(acetyloxy)ethyl]-5-methyl-1,2,4a,5,6,11b-hexahydro[1,3]dioxolo[4,5-j]phenanthridine-1,2-diyl diacetate
-
-
(2,6,6-trimethylcyclohex-1-en-1-yl)methyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
-
-
(22R)-22-hydroxystigmasta-4,9(11)-dien-3-one
-
i.e. haloxysterol , isolated from Haloxylon recurvum
(24S)-ethylcholesta-7,9(11),22(E)-triene-3beta-ol
-
isolated from Haloxylon recurvum
(2E)-1,3-diphenylprop-2-en-1-one
-
-
(2E)-1-(5-chloro-2-hydroxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one
-
-
(2E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one
-
-
(2E)-3-(3,4-dimethoxyphenyl)-1-phenylprop-2-en-1-one
-
-
(2E)-3-(3-hydroxyphenyl)-1-phenylprop-2-en-1-one
-
-
(2E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one
-
-
(2E)-3-(4-methoxyphenyl)-1-phenylprop-2-en-1-one
-
-
(3,4-dimethoxyphenyl)(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methanol
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (2,3-dimethylphenyl)carbamate
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (2,4,6-trimethylphenyl)carbamate
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (2,4-dimethylphenyl)carbamate
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (2,5-dimethylphenyl)carbamate
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (2,6-dimethylphenyl)carbamate
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (2-ethylphenyl)carbamate
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (3,4-dimethylphenyl)carbamate
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (3-methylphenyl)carbamate
-
-
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl (4-methylphenyl)carbamate
-
-
(3beta,4beta,5beta,6beta,8xi,9xi,14xi,17xi,22R)-4,28-dihydroxy-3-methoxy-1,26-dioxo-5,6:22,26-diepoxyergost-24-en-19-oic acid
-
isolated from Withania somnifera, noncompetitive inhibition
(3beta,4beta,5beta,6beta,8xi,9xi,14xi,17xi,22R)-4,28-dihydroxy-3-methoxy-5,6:22,26-diepoxyergost-24-ene-1,26-dione
-
isolated from Withania somnifera, noncompetitive inhibition
(3beta,4beta,6beta,8xi,9xi,14xi,17xi,22R)-4,6,27-trihydroxy-3-methoxy-22,26-epoxyergost-24-ene-1,26-dione
-
isolated from Withania somnifera, noncompetitive inhibition
(3E)-3-([4-[2-(diethylamino)ethoxy]phenyl]methylidene)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
(3E)-3-([4-[3-(diethylamino)propoxy]phenyl]methylidene)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
(3E)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
(3E)-3-[(4-[2-[diethenyl(methylidene)-l5-azanyl]ethoxy]phenyl)methylidene]-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
(3E)-3-[(4-[3-[diethenyl(methylidene)-l5-azanyl]propoxy]phenyl)methylidene]-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
(3R,4aS,9bS)-9-(chloromethyl)-9b-[2-[(ethoxycarbonyl)(methyl)amino]ethyl]-6-methoxy-3,4,4a,9b-tetrahydrodibenzo[b,d]furan-3-yl ethyl carbonate
-
-
(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,10,11,13,14-hexahydro-4aH,9H-[1]benzofuro[3a,3,2-gh][3,4]benzoxazonin-6-ol
-
-
(4aS,6R,8aS)-3-methoxy-11-[8-[(4aS,6R,8aS)-3-methoxy-6-methyl-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11(12H)-yl]octyl]-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol
-
-
(4aS,6R,8aS)-3-[[12-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)dodecyl]oxy]-6-hydroxy-11-methyl-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium
-
-
(4aS,6R,8aS)-3-[[8-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]oxy]-6-hydroxy-11-methyl-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium
-
-
(4aS,6R,8aS)-6-hydroxy-3-methoxy-11-[10-[(4aS,6R,8aS)-3-methoxy-6-methyl-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11(12H)-yl]decyl]-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium
-
-
(4aS,6R,8aS)-6-hydroxy-3-methoxy-11-[8-[(4aS,6R,8aS)-3-methoxy-6-methyl-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11(12H)-yl]octyl]-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium
-
-
(4aS,6R,8aS)-6-hydroxy-3-methyl-11-(10-phenyldecyl)-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium
-
-
(4aS,6R,8aS)-6-hydroxy-3-methyl-11-(8-phenyloctyl)-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium
-
-
(4beta,5beta,6beta,8xi,9xi,14xi,17xi,22R)-4,27-dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione
-
isolated from Ajuga bracteosa, noncompetitive inhibition
(5alpha,6alpha,7alpha,8xi,9xi,14xi,17xi,22R)-5-hydroxy-20-methyl-6,7:22,26-diepoxyergosta-2,24-diene-1,26-dione
-
isolated from Ajuga bracteosa, noncompetitive inhibition
(6,7-dimethoxyisoquinolin-1-yl)(2-methoxyphenyl)methanol
-
-
(6,7-dimethoxyisoquinolin-1-yl)(3,4-dimethoxyphenyl)methanol
-
-
(6,7-dimethoxyisoquinolin-1-yl)(3,4-dimethoxyphenyl)methanone
-
-
(8Z)-5,6-dihydro-8H-isoquino[1,2b]quinazolin-8-imine
-
-
(9E,9'E)-N,N'-hexane-1,6-diylbis(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine)
-
-
(9E,9'Z)-N,N'-heptane-1,7-diylbis(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine)
-
-
(R,S)-1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride
-
E2020, acetylcholinesterase inhibitor used in treatment of Alzheimer's disease, interacts with the active site and the peripheral anionic site of the enzyme
(S)-3-benzoyloxy-1-benzylquinuclidinium bromide
-
inhibition at 0.01 mM and 0.02 mM
(Z)-N1-methyl-N4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylidene)-N1-(3-((E)-8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-butane-1,4-diamine
-
-
1,2,11,12-tetramethoxy-7-methyl-5,6-dihydro-4H,8H-pyrido[3,2,1-de]phenanthridinium
-
-
1,2,3,10,11-pentamethoxy-7-(methoxycarbonyl)-5,6-dihydro-4H,8H-pyrido[3,2,1-de]phenanthridinium
-
-
1,2,3,4,9,9a-hexahydroacridin-9-amine
-
-
1,2-di(berberine-9-O-yl)ethane dibromide
-
-
1,2-dimethyl-beta-carbolin-2-ium iodide
-
noncompetitive inhibition
1,3-di(berberine-9-O-yl)propane dibromide
-
-
1,4-dichlorobenzene
-
reversible
1,5,6-trimethyl-9-oxo-7H,9H-pyrano[3,4,5-ij]isoquinolin-1-ium
-
-
1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline
-
-
1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methylisoquinolinium
-
-
1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisoquinoline
-
-
1-(hydroxymethyl)-5-methyloctahydro-2H-quinolizinium
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
1-dehydrotestosterone
-
-
1-epideacetylbowdensine
-
-
1-methyl-1-[2-oxo-3-(7-oxo-7H-dibenzo[de,h]quinolin-9-yl)propyl]pyrrolidinium
-
-
1-methyl-1-[3-oxo-4-(7-oxo-7H-dibenzo[de,h]quinolin-9-yl)butyl]pyrrolidinium
-
-
1-methyl-1-[4-oxo-5-(7-oxo-7H-dibenzo[de,h]quinolin-9-yl)pentyl]pyrrolidinium
-
-
1-methyl-3-(3-(methylamino)cyclohexyl)pyridinium
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
1-methyl-4,5-dihydro[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridin-6-ium-2-olate
-
-
10-methoxy-9-(4-phenoxybutoxy)-5,6-dihydro[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium bromide
-
-
10-[4-[(diethylamino)methyl]phenoxy]-N,N-diethyldecan-1-amine
-
-
10-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropyldecan-1-amine
-
-
11alpha,17beta-dihydroxyandrost-1,4-dien-3-one
-
-
11alpha-hydroxyandrost-1,4-dien-3,17-dione
-
-
11alpha-hydroxyandrost-4-en-3,17-dione
-
-
11alpha-hydroxytestolactone
-
-
11alpha-hydroxytestosterone
-
-
12-n-butoxy-demethoxykesselringine
-
-
13-methyl-5,8-dihydro-6H isoquino[1,2b]quinazolin-13-ium chloride
-
-
13-methyl-5,8-dihydro-6H-isoquino[1,2b]quinazolin-13-ium chloride
-
-
14-ethoxy-14-oxogalanthamine
-
-
15alpha,16alpha-epoxy-17-hydroxy-ent-kauran-19-oic acid
-
-
16 alpha-hydroxy-17-isovaleroyloxy-ent-kauran-19-oic acid
-
-
16alpha,17-dihydroxy-ent-kauran-19-oic acid
-
-
17-hydroxy-ent-kaur-15-en-19-oic acid
-
-
17beta-hydroxy-5alpha-androstan-3,6-dione
-
-
18-nor-ent-Kaur-16-ene-4 beta-ol
-
-
18-nor-ent-pimara-8(14),15-diene-4 beta-ol
-
-
19,20-dihydroervahanin A
-
-
19,20-dihydrotabernamine
-
-
2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
2-(6-oxo-7,11-diazatricyclo(7.3.1.0 2,7)tridec-11-yl)ethyl acetate
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
2-(trifluoromethyl)phenyl butylcarbamate
-
-
2-acetamido-N-(4-(8,9,10,11-tetrahydro-6H-azocino-[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,-11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)acetamide
-
-
2-chlorophenyl 1,2-dimethylhydrazinecarboxylate
-
-
2-chlorophenyl 1-methylhydrazinecarboxylate
-
-
2-chlorophenyl butylcarbamate
-
-
2-decanol
-
42,0% inhibition at 1 mM
2-ethyl-1-methyl-beta-carbolin-2-ium iodide
-
noncompetitive inhibition
2-ethylphenyl butylcarbamate
-
-
2-methoxyphenyl butylcarbamate
-
-
2-methylphenyl butylcarbamate
-
-
2-nitrophenyl butylcarbamate
-
-
2-tert-butoxyphenyl butylcarbamate
-
-
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one
-
-
2-[cyano(3-indolyl)methylene]-3-indolone
-
an alkaloid isolated from Isatis tinctoria
2-[[2-[(5aS,7R,9aS)-1-formyl-7-hydroxy-4-methoxy-6,7-dihydrodibenzo[b,d]furan-9a(5aH)-yl]ethyl](methyl)amino]butanoic acid
-
-
2-[[2-[(5aS,7R,9aS)-7-hydroxy-1-(hydroxymethyl)-4-methoxy-6,7-dihydrodibenzo[b,d]furan-9a(5aH)-yl]ethyl](methyl)amino]butanoic acid
-
-
24-ethyl-cholest-7-ene-3,5,6-triol
-
isolated from Haloxylon recurvum
24-ethylcholest-6-ene-3,5-diol
-
isolated from Haloxylon recurvum
2alpha,11alpha-dihydroxyfawcettiine
-
-
2beta-hydroxyepipachysamine D
-
-
3'-hydroxyepiglucoisatisin
-
an alkaloid isolated from Isatis tinctoria
3,3'-((1,5-dioxopentane-1,5-diyl)bis(iminocyclohexane-3,1-diyl))bis(1-methylpyridinium)
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
3,3'-[butane-1,4-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
-
-
3,3'-[butane-1,4-diylbis(oxy)]bis(7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine)
-
-
3,3'-[butane-1,4-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
-
-
3,3'-[dodecane-1,12-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
-
-
3,3'-[dodecane-1,12-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
-
-
3,3'-[hexane-1,6-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
-
-
3,3'-[hexane-1,6-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
-
-
3,3'-[octane-1,8-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
-
-
3,3'-[octane-1,8-diylbis(oxy)]bis(7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine)
-
-
3,3'-[octane-1,8-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
-
-
3,3'-[pentane-1,5-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
-
-
3,3'-[pentane-1,5-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
-
-
3,3'-[propane-1,3-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
-
-
3,3'-[propane-1,3-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
-
-
3-(4-propoxybenzyl)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
3-(4-[2-[diethenyl(methylidene)-l5-azanyl]ethoxy]benzyl)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
3-(4-[3-[diethenyl(methylidene)-l5-azanyl]propoxy]benzyl)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
3-(6-oxo-6-(8-oxooctahydro-2H-2,6-methanopyrido(1,2-a)(1,5)diazocin-3(4H)-yl)hexanoyl)decahydro-8H-1,5-methanopyrido(1,2-a)(1,5)diazocin-8-one
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
3-(9-hydroxy-5,6-dimethyl-7H,9H-pyrano[3,4,5-ij]isoquinolin-9-yl)propane-1,2-diol
-
-
3-(9-methoxy-5,6-dimethyl-7H,9H-pyrano[3,4,5-ij]isoquinolin-9-yl)propane-1,2-diol
-
-
3-carene
-
50% inhibition at 2 mM
3-chlorophenyl 1,2-dimethylhydrazinecarboxylate
-
-
3-chlorophenyl 1-methylhydrazinecarboxylate
-
-
3-hydroxy-2,2,6-trimethyl-3,4,5,6-tetrahydro-2H-pyrano[3,2c] quinoline 5-one
-
isolated from Skimmia laureola
3-methoxy-7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium iodide
-
micromolar non-selective inhibitor
3-methyl-N-(4-(8,9,10,11-tetrahydro-6H-azocino-[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,-10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)butanamide
-
-
3-N,N-diethylaminophenyl-N'-(1-alkyl) carbamates
-
inhibit quickly by carbamoylation
3-N,N-diethylaminophenyl-N'-(1-butyl) carbamate
-
-
3-N,N-diethylaminophenyl-N'-(1-ethyl) carbamate
-
-
3-N,N-diethylaminophenyl-N'-(1-hexyl) carbamate
-
-
3-N,N-diethylaminophenyl-N'-(1-octyl) carbamate
-
-
3-N,N-diethylaminophenyl-N'-(1-propyl) carbamate
-
-
3-[4-[3-(diethylamino)propoxy]benzyl]-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
-
-
4,5-diethyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-chlorophenyl 1,2-dimethylhydrazinecarboxylate
-
-
4-chlorophenyl 1-methylhydrazinecarboxylate
-
-
4-cymene
-
isolated from Melaleuca atlernifolia
4-ethenyl-5-ethyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-ethenyl-5-hexyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-ethenyl-5-methyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-ethenyl-5-pentyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-ethenyl-5-propyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-ethyl-5-hexyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine hydrobromide
-
-
4-ethyl-5-methyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-ethyl-5-pentyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-ethyl-5-propyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
4-ethyl-N-methyl-dihydrophenanthridine
-
-
4-isopropyl benzaldehyde
-
30.4% inhibition at 1 mM
4-methyl-N-(4-(8,9,10,11-tetrahydro-6H-azocino-[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,-10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)pentanamide
-
-
4-Methylumbelliferone
-
80.9% inhibition at 1 mM
4-[4-[(diethylamino)methyl]phenoxy]-N,N-diethylbutan-1-amine
-
-
4-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropylbutan-1-amine
-
-
5,6-dimethoxy-9-prop-2-en-1-yl-7H,9H-pyrano[3,4,5-ij]isoquinolin-9-ol
-
-
5,7,8,13-tetrahydroindolo [2',3':3,4]pyrido[2,1-b]quinazoline
-
-
5,8-dihydro-6H isoquino[1,2b]quinazoline
-
-
5-butyl-4-ethenyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
5-butyl-4-ethyl-5,6-dihydro[1,3]dioxolo[4,5-j]phenanthridine
-
-
5-hydroxy-5,6-seco-dihydrolycorine
-
-
5-hydroxy-5,6-secolycorine
-
-
5-[4-[(diethylamino)methyl]phenoxy]-N,N-diethylpentan-1-amine
-
-
5-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropylpentan-1-amine
-
-
5alpha,8alpha-epidioxy-(24S)-ethylcholesta-6,9(11),22(E)-triene-3beta-ol
-
isolated from Haloxylon recurvum
6-chloro-2-methyl-9H-beta-carbolin-2-ium iodide
-
-
6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium iodide
-
-
6-O-demethylgalanthamine
-
-
6-[4-[(diethylamino)methyl]phenoxy]-N,N-diethylhexan-1-amine
-
-
6-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropylhexan-1-amine
-
-
7(R,S)-1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride
-
-
7-bromo-6-methyl-7H,9H-pyrano[3,4,5-ij]isoquinolin-9-one
-
-
7-methyloctahydro-2H-quinolizin-1-yl (7-methyloctahydro-2H-quinolizin-1-yl)methyl butanedioate
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
7-oxo-ent-pimara-8(14),15-diene-19-oic acid
-
-
8-alpha-ethoxyprecriwelline
-
-
8-methoxypsoralen
-
67.1% inhibition at 1 mM
8-[4-[(diethylamino)methyl]phenoxy]-N,N-diethyloctan-1-amine
-
-
8-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropyloctan-1-amine
-
-
9,10-dimethoxy-1,2,3,12,15,16-hexadehydrogalanthan
-
-
9-(2-oxo-3-pyrrolidin-1-ylpropyl)-7H-dibenzo[de,h]quinolin-7-one
-
-
9-(2-oxo-4-pyrrolidin-1-ylbutyl)-7H-dibenzo[de,h]quinolin-7-one
-
-
9-(2-oxo-5-pyrrolidin-1-ylpentyl)-7H-dibenzo[de,h]quinolin-7-one
-
-
9-(4-[[2-(dimethylamino)ethyl]amino]-2-oxobutyl)-7H-dibenzo[de,h]quinolin-7-one
-
-
9-O-[(2-(3-methyl)pyridinium bromide)ethyl]-berberine bromide
-
-
9-O-[(2-pyridinium)bromide ethyl]-berberine bromide
-
-
9-O-[(3-o xo-3-p-chlorophenylamino)propyl]-berberine bromide
-
-
9-O-[(3-oxo-3-p-methoxyamino)propyl]-berberine bromide
-
-
9-O-[(3-oxo-3-p-nitrophenylamino)propyl]-berberine bromide
-
-
9-O-[(3-oxo-3-p-tolylamino)propyl]-berberine bromide
-
-
9-O-[(3-oxo-3-phenylamino)propyl]-berberine bromide
-
-
9-O-[(3-pyridinium bromide)propyl]-berberine bromide
-
-
9-O-[3-(2-pyridinoxyl)butyl]-berberine bromide
-
-
9-O-[3-(3-methyl pyridinium bromide)propyl]-berberine bromide
-
-
9-O-[3-(4-bromo-phenoxyl)butyl]-berberine bromide
-
-
9-O-[3-(4-bromo-phenoxyl)propyl]-berberine bromide
-
-
9-O-[3-(4-chloro-phenoxyl) butyl]-berberine bromide
-
-
9-O-[3-(4-chloro-phenoxyl)propyl]-berberine bromide
-
-
9-O-[3-(4-methoxy-phenoxyl)-propyl]-berberine bromide
-
-
9-O-[3-(4-methoxy-phenoxyl)butyl]-berberine bromide
-
-
9-O-[3-(4-methyl-phenoxyl) propyl]-berberine bromide
-
-
9-O-[3-(4-nitro-phenoxyl)butyl]-berberine bromide
-
-
9-O-[3-(4-nitro-phenoxyl)propyl]-berberine bromide
-
-
9-O-[3-(N-methyl-phenylamino)propyl]-berberine bromide
-
-
9-O-[3-(naphthalen-2-yloxy)butyl]-berberine bromide
-
-
9-O-[3-(naphthalen-2-yloxy)propyl]-berberine bromide
-
-
9-O-[3-(naphthalene-2-ylthio)butyl]-berberine bromide
-
most potent BuChE inhibito
9-O-[3-(naphthalene-2-ylthio)propyl]-berberine bromide
-
-
9-O-[3-(phenylamino)propyl]-berberine bromide
-
-
9-[3-(dimethylamino)-2-oxopropyl]-7H-dibenzo[de,h]quinolin-7-one
-
-
9-[4-(diethylamino)-2-oxobutyl]-7H-dibenzo[de,h]quinolin-7-one
-
-
9-[4-(dimethylamino)-2-oxobutyl]-7H-dibenzo[de,h]quinolin-7-one
-
-
9-[4-[(2-hydroxyethyl)amino]-2-oxobutyl]-7H-dibenzo[de,h]quinolin-7-one
-
-
9-[5-(dimethylamino)-2-oxopentyl]-7H-dibenzo[de,h]quinolin-7-one
-
-
abamectin
-
is a potent inhibitor of horse serum butyrylcholinesterase which interacts with the enzyme in a reversible, competitive manner predictively to block the mouth of the active-site gorge of the enzyme and to bind to several critical residues that normally bind/hydrolyze choline esters. Abamectin is a blend of natural avermectins B1a and B1b. Avermectins potentiate the ability of certain neurotransmitters (GABA and/or glutamate) to trigger an influx of Cl- ions carried by neurotransmitter-gated chloride channels in target organisms. Competitive versus butyrylthiocholine. Docking study, BChE-avermectin docking and interaction profiling, overview
alpha-pinene
-
23.5% inhibition at 1 mM
alpha-terpinen
-
isolated from Melaleuca atlernifolia
androst-1,4-dien-3,17-dione
-
-
androst-4-en-3,7-dione
-
-
Anethum graveolens essential oil
-
90.9% inhibition
-
avermectin B1a
-
engagement of avermectin B1a in a hydrogen-bonding interaction with the catalytic serine
baicalein
-
an alkaloid isolated from Isatis tinctoria
beta-pinene
-
31.3% inhibition at 1 mM
biphenyl-2-yl butylcarbamate
-
-
bulbocapnine
-
isolated from Corydalis cava
buxabenzacinine
-
isolated from Buxus hyrcana
buxandrine
-
isolated from Buxus hyrcana
buxidin
-
isolated from Buxus hyrcana
buxippine-K
-
isolated from Buxus hyrcana
buxoviricine
-
isolated from Buxus hyrcana
chlorobenzene
-
reversible
citral
-
32.6% inhibition at 1 mM
citronellal
-
60.6% inhibition at 1 mM
citronellol
-
55.4% inhibition at 1 mM
corydine
-
specific for BChE
cuminyl alcohol
-
18.1% inhibition at 1 mM
D-borneol
-
12.1% inhibition at 1 mM
dec-N-dimethylregeline
-
-
dehydroevodiamine hydrochloride
-
isolated from Evodia rutaecarpa
diethylphosphochloridate
-
-
diethylphosphofluoridate
-
-
dihydrocarvone
-
66.5% inhibition at 1 mM
diisopropylfluorophosphate
-
DFP, selective inhibitor
diisopropylphosphofluoridate
-
diisopropyl fluorophosphate
ent-kaur-16-en-19-oic-acid
-
-
ent-pimar-15-en-8 alpha, 19-diol
-
-
ent-pimara-8(14),15-diene-19-oic acid
-
-
ent-pimara-8(14),15-diene-19-ol
-
-
epiglucoisatisin
-
an alkaloid isolated from Isatis tinctoria
ethanolic extract from Pimpinella anisodes
-
IC50: 362.1 microgram/ml
-
ethyl [2-[(5aS,7R,9aS)-1-formyl-7-hydroxy-4-methoxy-6,7-dihydrodibenzo[b,d]furan-9a(5aH)-yl]ethyl]methylcarbamate
-
-
ethyl [2-[(5aS,7R,9aS)-7-hydroxy-1-(hydroxymethyl)-4-methoxy-6,7-dihydrodibenzo[b,d]furan-9a(5aH)-yl]ethyl]methylcarbamate
-
-
eugenol
-
45.4% inhibition at 1 mM
farnesol
-
33.0% inhibition at 1 mM
Foeniculum vulgare essential oil
-
gamma-terpinen
-
isolated from Melaleuca atlernifolia
geraniol
-
21.1% inhibition at 1 mM
geranyl ester
-
59.1% inhibition at 1 mM
Harmane
-
noncompetitive inhibition
hyrcamine
-
isolated from Buxus hyrcana
hyrcanone
-
isolated from Buxus hyrcana
hyrcatrienine
-
isolated from Buxus hyrcana
iolantamine iodomethylate
-
-
isatan A
-
an alkaloid isolated from Isatis tinctoria
isatan B
-
an alkaloid isolated from Isatis tinctoria
iso-menthone
-
64.7% inhibition at 1 mM
iso-pulegol
-
44.7% inhibition at 1 mM
isolariin A
-
isolated from Linaria reflexa
isolariin B
-
isolated from Linaria reflexa
isoquinolin-1-yl(2-methoxyphenyl)methanol
-
-
kesselridine iodomethylate
-
-
Lavandula officinalis essential oil
-
lawsaritol
-
isolated from Haloxylon recurvum
leufolin A
-
isolated from Leucas urticifolia
leufolin B
-
isolated from Leucas urticifolia
linalyl ester
-
35.8% inhibition at 1 mM
linalyl oxide
-
29.0% inhibition at 1 mM
luteidine iodomethylate
-
-
Melissa officinalis essential oil
-
Mentha piperita essential oil
-
organic fertilizer, 93.5% inhibition
-
Mentha spicata essential oil
-
organic fertilizer, 91.0% inhibition
-
menthofurane
-
55.4% inhibition at 1 mM
menthol
-
70.0% inhibition at 1 mM
methyl isoplatydesmine
-
specific for BChE
N,N'-bis(3-pyridin-3-ylcyclohexyl)pentanediamide
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
N,N,N,N',N',N'-hexamethylbutane-1,4-diaminium
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
N,N,N-trimethyl-2-oxo-3-(7-oxo-7H-dibenzo[de,h]quinolin-9-yl)propan-1-aminium
-
-
N,N,N-trimethyl-3-oxo-4-(7-oxo-7H-dibenzo[de,h]quinolin-9-yl)butan-1-aminium
-
-
N,N,N-trimethyl-4-oxo-5-(7-oxo-7H-dibenzo[de,h]quinolin-9-yl)pentan-1-aminium
-
-
N,N,N-trimethylmethanaminium
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
N,N-bis(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl) acetamide
-
-
N,N-bis(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)acetamide
-
-
N,N-dibutyl-10-[4-[(diethylamino)methyl]phenoxy]decan-1-amine
-
-
N,N-dibutyl-4-[4-[(diethylamino)methyl]phenoxy]butan-1-amine
-
-
N,N-dibutyl-5-[4-[(diethylamino)methyl]phenoxy]pentan-1-amine
-
-
N,N-dibutyl-6-[4-[(diethylamino)methyl]phenoxy]hexan-1-amine
-
-
N,N-dibutyl-8-[4-[(diethylamino)methyl]phenoxy]octan-1-amine
-
-
N-(2-phenylethyl)-N-[(12Z)-7,8,9,10-tetrahydroazepino [2,1b]quinazolin-12(6H)-ylidene]amine
-
-
N-(4-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)butyl)-N-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl) methacrylamide
-
-
N-(4-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)butyl)-N-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl) propionamide
-
-
N-(4-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)butyl)-N-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl)acetamide
-
-
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro--6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-acetamide
-
-
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-methacrylamide
-
-
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-pentanamide
-
-
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-pivalamide
-
-
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-propionamide
-
-
N-desmethyl-8alpha-ethoxypretazzettine
-
-
N-desmethyl-8beta-ethoxypretazzettine
-
-
N-ethyl-N-(4-[[10-(4-ethylpiperazin-1-yl)decyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[10-(4-methylpiperazin-1-yl)decyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[10-(piperidin-1-yl)decyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[10-(pyrrolidin-1-yl)decyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[5-(4-ethylpiperazin-1-yl)pentyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[5-(4-methylpiperazin-1-yl)pentyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[5-(piperidin-1-yl)pentyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[5-(pyrrolidin-1-yl)pentyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[6-(4-ethylpiperazin-1-yl)hexyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[6-(4-methylpiperazin-1-yl)hexyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[6-(piperidin-1-yl)hexyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[6-(pyrrolidin-1-yl)hexyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[8-(4-ethylpiperazin-1-yl)octyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[8-(4-methylpiperazin-1-yl)octyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[8-(piperidin-1-yl)octyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-(4-[[8-(pyrrolidin-1-yl)octyl]oxy]benzyl)ethanamine
-
-
N-ethyl-N-[4-[2-(4-methylpiperazin-1-yl)ethoxy]benzyl]ethanamine
-
-
N-ethyl-N-[4-[2-(piperidin-1-yl)ethoxy]benzyl]ethanamine
-
-
N-ethyl-N-[4-[4-(4-methylpiperazin-1-yl)butoxy]benzyl]ethanamine
-
-
N-ethyl-N-[4-[4-(piperidin-1-yl)butoxy]benzyl]ethanamine
-
-
N-ethyl-N-[4-[4-(pyrrolidin-1-yl)butoxy]benzyl]ethanamine
-
-
N-methyl-3-pyridin-3-ylcyclohexanamine
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
N1-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylidene)-N3-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl)-N3-methylpropane-1,3-diamine
-
-
N1-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylidene)-N4-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl)-N4-methylbutane-1,4-diamine
-
-
N1-methyl-N3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylidene)-N1-(3-(8,9,10,11-tetrahydro-6Hazocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)propane-1,3-diamine
-
-
N3-demethylsaracodine
-
-
Nb-dimethylcycloxobuxoviricine
-
isolated from Buxus hyrcana
nerol
-
30.8% inhibition at 1 mM
O-(4-bromo-2-[[3-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
-
-
O-(4-bromo-2-[[4-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
-
least effective inhibitor
O-(4-chloro-2-[[3-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
-
-
O-(4-chloro-2-[[4-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
-
-
O-(5-chloro-2-[[3-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
-
-
O-(5-chloro-2-[[4-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
-
-
O-ethyl-S-ethyl methylthiophosphonate
-
-
O-ethyl-S-pentyl methylthiophosphonate
-
LG-64
O-hexyl-S-ethyl methylthiophosphonate
-
-
O-isopropyl S-(diisopropylaminoethyl) methyl thiophosphonate
-
-
O-[2-[(3-bromophenyl)carbamoyl]-4-chlorophenyl] O,O-diethyl phosphorothioate
-
-
O-[2-[(3-bromophenyl)carbamoyl]-5-chlorophenyl] O,O-diethyl phosphorothioate
-
-
O-[2-[(4-bromophenyl)carbamoyl]-4-chlorophenyl] O,O-diethyl phosphorothioate
-
-
O-[2-[(4-bromophenyl)carbamoyl]-5-chlorophenyl] O,O-diethyl phosphorothioate
-
-
O-[4-bromo-2-[(3,4-dichlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-bromo-2-[(3-bromophenyl)carbamoyl]phenyl] diethyl phosphate
-
-
O-[4-bromo-2-[(3-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-bromo-2-[(3-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-bromo-2-[(4-bromophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-bromo-2-[(4-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-bromo-2-[(4-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-chloro-2-[(3,4-dichlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-chloro-2-[(3-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-chloro-2-[(3-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[4-chloro-2-[(4-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[5-chloro-2-[(3,4-dichlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[5-chloro-2-[(3-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[5-chloro-2-[(3-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
second best inhibitor
O-[5-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
-
O-[5-chloro-2-[(4-fluorophenyl)-carbamoyl]phenyl] O,O-diethyl phosphorothioate
-
most efficient inhibitor
Ocimum basilicum essential oil
-
octahydro-2H-quinolizin-1-yl octahydro-2H-quinolizin-1-ylmethyl butanedioate
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
octahydro-2H-quinolizin-1-ylmethanol
-
pKi-values and comparison with inhibitory effect on human acetylcholinesterase EC 3.1.1.7 and Berrytheutis magister butyrylcholinesterase EC 3.1.1.8
Origanum majorana essential oil
-
organic fertilizer, 94.4% inhibition
-
Origanum munitiflorum essential oil
-
organic fertilizer, 94.7% inhibition
-
Origanum onites essential oil
-
organic fertilizer, 92.9% inhibition
-
Origanum vulgare essential oil
-
organic fertilizer, 88.4% inhibition
-
oxazaphenalene lactone
-
-
p-hydroxybenzoic acid
-
-
paraoxon
-
paraoxon binds to both the enzyme and acyl-enzyme, but with weak affinities. A slight activation is observed at the lowest paraoxon concentrations and is attributed to the binding of the substrate to the enzyme-inhibitor complex
phenyl 1,2-dimethylhydrazinecarboxylate
-
-
phenyl 1-methylhydrazinecarboxylate
-
-
phenyl butylcarbamate
-
-
piperitone
-
76.1% inhibition at 1 mM
regeline iodomethylate
-
-
salignarine-C
-
isolated from Sarcococca saligna
Salvia officinalis essential oil
-
organic fertilizer, 66.3% inhibition
-
Salvia sclarea essential oil
-
sarcovagenine-C
-
isolated from Sarcococca saligna
Satureja cuneifolia essential oil
-
organic fertilizer, 98.4% inhibition
-
scopoletin
-
73.5% inhibition at 1 mM
slavin A
-
isolated from Salvia santolinifolia
slavin B
-
isolated from Salvia santolinifolia
sulfoglucobrassicin
-
an alkaloid isolated from Isatis tinctoria
taspine
-
isolated from Thymus vulgaris essential oil
terpinen-4-ol
-
isolated from Melaleuca atlernifolia
thymohydroquinone
-
isolated from Thymus vulgaris essential oil
thymoquinone
-
isolated from Thymus vulgaris essential oil
trans-anethole
-
identified compound of Pimpinella anisodes, IC50: 209.6 microgram/ml
umbelliferone
-
54.3% inhibition at 1 mM
Vanillin
-
8.5% inhibition at 1 mM
1,8-cineole
-
48.2% inhibition at 1 mM
1,8-cineole
-
isolated from Melaleuca atlernifolia
amlodipine besylate
-
-
amlodipine besylate
-
reversible mixed-type inhibition
carvacrol
-
54.6%inhibition at 1 mM
carvacrol
-
isolated from Thymus vulgaris essential oil
chlordiazepoxide HCl
-
-
chlordiazepoxide HCl
-
reversible mixed-type inhibition
cymserine
-
-
cymserine
-
BChE selective inhibitor
diazepam
-
-
diazepam
-
reversible mixed-type inhibition
ethopropazine
-
-
ethopropazine
-
inhibits at low substrate concentrations, inhibition mechanism
Foeniculum vulgare essential oil
-
flowering, 65.4% inhibition
-
Foeniculum vulgare essential oil
-
fully-mature, 71.6% inhibition
-
galanthamine
-
-
galanthamine
-
80.3% inhibition at 1 mM
galanthamine
-
an alkaloid isolated from Isatis tinctoria
hydralazine HCl
-
-
hydralazine HCl
-
reversible mixed-type inhibition
Lavandula officinalis essential oil
-
chemical fertilizer, 95.0% inhibition
-
Lavandula officinalis essential oil
-
organic fertilizer, 92.9% inhibition
-
linalool
-
15.7% inhibition at 1 mM
linalool
-
isolated from Thymus vulgaris essential oil
lovastatin
-
-
lovastatin
-
reversible mixed-type inhibition
Melissa officinalis essential oil
-
chemical fertilizer, 66.5% inhibition
-
Melissa officinalis essential oil
-
organic fertilizer, 73.3% inhibition
-
nifedipine
-
-
nifedipine
-
reversible mixed-type inhibition
Ocimum basilicum essential oil
-
green variety, 74.1% inhibition
-
Ocimum basilicum essential oil
-
purple variety, 79.1% inhibition
-
physostigmine
-
-
physostigmine
-
identified compound of Pimpinella anisodes, IC50: 0.17 microgram/ml
Salvia sclarea essential oil
-
chemical fertilizer, 45.1% inhibition
-
Salvia sclarea essential oil
-
organic fertilizer, 76.0% inhibition
-
simvastatin
-
-
simvastatin
-
reversible mixed-type inhibition
Thymol
-
27.6% inhibition at 1 mM
Thymol
-
isolated from Thymus vulgaris essential oil
additional information
design, synthesis, and biological evaluation of multifunctional tacrine-curcumin hybrids as cholinesterase inhibitors with metal ions-chelating and neuroprotective properties, overview. The hybrid compounds show good cholinesterase inhibitory activity, some of the compounds exhibit different selectivity on acetylcholinesterase (EC 3.1.1.7) or butyrylcholinesterase due to the structural difference. Structure-activity relationships, molecular modelling, overview
-
additional information
evaluation of a combination of both anticholinesterase and beta-amyloid anti-aggregation activities in one molecule, and therapeutic potential in vivo. Design and synthesis of 28 compounds as derivatives of donepezil that contain the N-benzylpiperidine moiety combined with the phthalimide or indole moieties. No or poor inhibition by 2-[5-[(1-benzylpiperidin-4-yl)amino]pentyl]-1H-isoindole-1,3(2H)-dione
-
additional information
evaluation of the potential of six dihydroxanthyletin-type coumarins, isolated from Angelica decursiva, to inhibit acetylcholinesterase (AChE, EC 3.1.1.7), butyrylcholinesterase (BChE), and beta-site amyloid precursor protein cleaving enzyme 1 (BACE1, EC 3.4.23.46), overview
-
additional information
in-vitro evaluation and in-silico studies on amide derivatives of N-phthaloylglycine as butyrylcholinesterase (BChE) inhibitors. The compounds dock into the binding pocket of butyrylcholinesterase enzyme showing interactive amino acid residues of the binding gorge, docking study, overview
-
additional information
molecular docking, modelling, overview
-
additional information
substrate inhibition with formylthiocholine does not occur
-
additional information
synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors, overview. Analysis of enzyme binding structure, structure-function analysis, modeling
-
additional information
synthesis, crystal structure determination, biological screening, and docking studies of N1-substituted derivatives of 2,3-dihydroquinazolin-4(1H)-one as inhibitors of cholinesterases, structure-activity relationships, overview
-
additional information
-
-
-
additional information
-
ortho electron domating substitutents of the inhibitors accelerate inhibition of enzyme by ortho polar effects
-
additional information
-
some inhibitors fullfill the competitive inhibition model with irreversible reaction between enzyme and inhibitor, but e.g. not galantamin
-
additional information
-
specificity of diverse reversible sulfonium inhibitors, overview
-
additional information
-
76% inhibition by a furanocoumarin mixture obtained from Heracleum crenatifolium, no inhibition by rhapontin, rhein, 4-hydroxycoumarin, aloe-emodine, bergapten and iso-bergapten
-
additional information
-
molecular docking analysis of inhibitors, overview
-
additional information
-
no inhibition by gamma-terpinene, 4-allyl anisole, cumol, trans-anethole, camphene, iso-borneol, l-bornyl acetate, and 2-heptanol
-
additional information
-
potency and mechanism of diverse enzyme inhibitors, corydaline and ribalinine, isolated from Skimmia laureola, are specific for acetylcholinesterase, overview
-
additional information
-
selectivity and inhibitory potency of isaindigotone derivatives for inhibition of BuChE
-
additional information
-
not inhibited by 3-methoxy-5,8,9,13b-tetrahydro-6H-isoquino-[1,2-a]isoquinoline and 3-methoxy-7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00187
(2E)-2-(4-hydroxy-3-methoxybenzylidene)-3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00211
(2E)-2-(4-hydroxy-3-methoxybenzylidene)-3-oxo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]butanamide
Equus caballus
pH 8.0, 37°C
0.0015
(2E)-2-(4-hydroxy-3-methoxybenzylidene)-3-oxo-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]butanamide
Equus caballus
pH 8.0, 37°C
0.0016
(2E)-2-(4-hydroxybenzylidene)-3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00477
(2E)-2-(4-hydroxybenzylidene)-3-oxo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00224
(2E)-2-(4-hydroxybenzylidene)-3-oxo-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00918
(6R,7S)-6-(acetyloxy)-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl (2Z)-2-methylbut-2-enoate
Equus caballus
pH 8.0, 22°C
0.00578
(6R,7S)-6-hydroxy-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl (2E)-2-methylbut-2-enoate
Equus caballus
pH 8.0, 22°C
0.00734
(6R,7S)-6-hydroxy-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl 3-methylbut-2-enoate
Equus caballus
pH 8.0, 22°C
0.00886
(6R,7S)-6-methoxy-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl 3-methylbut-2-enoate
Equus caballus
pH 8.0, 22°C
0.01391
(6R,7S)-7-hydroxy-8,8-dimethyl-2-oxo-7,8-dihydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-yl 4-methylpent-3-enoate
Equus caballus
pH 8.0, 22°C
0.1072
1,2,2-triethyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.1069
1,2-diethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.01102
1-(2-chloro-benzyl)-2,2-diethyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.01056
1-(2-chloro-benzyl)-2,2-diisobutyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0502
1-(2-chloro-benzyl)-2,2-dimethyl-2,3-dihydro-1Hquinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0196
1-(2-chloro-benzyl)-2-(4-chloro-phenyl)-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0332
1-(2-chloro-benzyl)-2-ethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.046
1-(2-chloro-benzyl)-2-isobutyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0196
1-(2-chloro-benzyl)-2-methyl-2-phenyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0065
1-(2-chloro-benzyl)-2-methyl-2-propyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.00083
1-(2-fluorobenzyl)-N-[6-(1H-indol-1-yl)hexyl]piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.00075
1-(2-fluorobenzyl)-N-[8-(1H-indol-1-yl)octyl]piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.00178
1-(3-chlorobenzyl)-N-[6-(1H-indol-1-yl)hexyl]piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.00133
1-(3-chlorobenzyl)-N-[8-(1H-indol-1-yl)octyl]piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.0237
1-(4-chloro-benzyl)-2,2-diethyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.00156
1-(4-chloro-benzyl)-2,2-diisobutyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.00448
1-(4-chloro-benzyl)-2-(4-chloro-phenyl)-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0189
1-(4-chloro-benzyl)-2-ethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0115
1-(4-chloro-benzyl)-2-isobutyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0205
1-(4-chloro-benzyl)-2-methyl-2-phenyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0046
1-(4-chloro-benzyl)-2-methyl-2-propyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0165
1--(4-chloro-benzyl)-2,2-dimethyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0045
1-benzyl-2,2-diethyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.00248
1-benzyl-2,2-diisobutyl-2,3-dihydro-1Hquinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0224
1-benzyl-2,2-dimethyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.00376
1-benzyl-2-(4-chloro-phenyl)-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0354
1-benzyl-2-ethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.00357
1-benzyl-2-isobutyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0217
1-benzyl-2-methyl-2-phenyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0445
1-benzyl-2-methyl-2-propyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0153
1-benzyl-N-[3-(2,3-dihydro-1H-indol-1-yl)propyl]piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.00108
1-benzyl-N-[5-(2,3-dihydro-1H-indol-1-yl)pentyl]piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.00341
1-benzyl-N-[6-(1H-indol-1-yl)hexyl]piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.00093
1-benzyl-N-[8-(1H-indol-1-yl)octyl]piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.0418
1-ethyl-2,2-diisobutyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0709
1-ethyl-2,2-dimethyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0998
1-ethyl-2-isobutyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.0614
1-ethyl-2-methyl-2-phenyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.1261
1-ethyl-2-methyl-2-propyl -2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.01052
2-(3-[[1-(2-fluorobenzyl)piperidin-4-yl]amino]propyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00453
2-(3-[[1-(3-chlorobenzyl)piperidin-4-yl]amino]propyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00937
2-(3-[[1-(4-hydroxybenzyl)piperidin-4-yl]amino]propyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.0268
2-(3-[[1-(4-methoxybenzyl)piperidin-4-yl]amino]propyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.0974
2-(4-chloro-phenyl)-1-ethyl-2-methyl-2,3-dihydro-1H-quinazolin-4-one
Equus caballus
pH and temperature not specified in the publication
0.00131
2-(4-hydroxy-3-methoxybenzyl)-3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00338
2-(4-hydroxy-3-methoxybenzyl)-3-oxo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00022
2-(4-hydroxy-3-methoxybenzyl)-3-oxo-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00083
2-(4-hydroxybenzyl)-3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00039
2-(4-hydroxybenzyl)-3-oxo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]butanamide
Equus caballus
pH 8.0, 37°C
0.0002
2-(4-hydroxybenzyl)-3-oxo-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]butanamide
Equus caballus
pH 8.0, 37°C
0.004
2-(6-[[1-(2-fluorobenzyl)piperidin-4-yl]amino]hexyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00273
2-(6-[[1-(3-chlorobenzyl)piperidin-4-yl]amino]hexyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00232
2-(6-[[1-(4-hydroxybenzyl)piperidin-4-yl]amino]hexyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00739
2-(6-[[1-(4-methoxybenzyl)piperidin-4-yl]amino]hexyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00187
2-(8-[[1-(2-fluorobenzyl)piperidin-4-yl]amino]octyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00072
2-(8-[[1-(3-chlorobenzyl)piperidin-4-yl]amino]octyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00081
2-(8-[[1-(4-hydroxybenzyl)piperidin-4-yl]amino]octyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00565
2-(8-[[1-(4-methoxybenzyl)piperidin-4-yl]amino]octyl)-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00017
2-[(5-acetyl-6-methyl-4-phenyl-1,4-dihydropyrimidin-2-yl)sulfanyl]-N-phenylacetamide
Equus caballus
pH and temperature not specified in the publication
0.0518
2-[3-[(1-benzylpiperidin-4-yl)amino]propyl]-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.01285
2-[6-[(1-benzylpiperidin-4-yl)amino]hexyl]-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00198
2-[8-[(1-benzylpiperidin-4-yl)amino]octyl]-1H-isoindole-1,3(2H)-dione
Equus caballus
pH 8.0, 25°C
0.00039
2-[[5-acetyl-6-methyl-4-(4-phenoxyphenyl)-1,4-dihydropyrimidin-2-yl]sulfanyl]-N-phenylacetamide
Equus caballus
pH and temperature not specified in the publication
0.00031
3-oxo-N-[(1,2,3,4-tetrahydroacridin-9-ylamino)methyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00006
3-oxo-N-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00016
3-oxo-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00022
3-oxo-N-[5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]butanamide
Equus caballus
pH 8.0, 37°C
0.00052
4-[(4-[[6-(1H-indol-1-yl)hexyl]amino]piperidin-1-yl)methyl]phenol
Equus caballus
pH 8.0, 25°C
0.00034
4-[(4-[[8-(1H-indol-1-yl)octyl]amino]piperidin-1-yl)methyl]phenol
Equus caballus
pH 8.0, 25°C
0.0016
6,8-dibromo-2-(4-chlorophenyl)-2-methyl-2,3-dihydroquinazolin-4(1H)-one
Equus caballus
pH and temperature not specified in the publication
0.0279
6-formylumbelliferone
Equus caballus
pH 8.0, 22°C
0.08767
8-formylumbelliferone
Equus caballus
pH 8.0, 22°C
0.00744 - 0.00981
Berberine
0.00937
decursidin
Equus caballus
pH 8.0, 22°C
7.4
N,N-di-sec-butyl-2-(1,3-dioxoisoindolin-2-yl)acetamide
Equus caballus
pH 8.0, 25°C
6.5
N,N-dibutyl-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetamide
Equus caballus
pH 8.0, 25°C
17.2
N,N-dicyclohexyl-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetamide
Equus caballus
pH 8.0, 25°C
136
N-(cyclohexyl)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-methylacetamide
Equus caballus
pH 8.0, 25°C
0.00813
N-[6-(1H-indol-1-yl)hexyl]-1-(4-methoxybenzyl)piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.00446
N-[8-(1H-indol-1-yl)octyl]-1-(4-methoxybenzyl)piperidin-4-amine
Equus caballus
pH 8.0, 25°C
0.00005
tacrine
Equus caballus
pH 8.0, 37°C
0.09014
umbelliferone
Equus caballus
pH 8.0, 22°C
0.0186
(-)-galanthamine
Equus caballus
-
-
0.000027
(13E,13'Z)-N,N'-hexane-1,6-diylbis(6,7,8,9,10,11-hexahydro-13H-azocino[2,1-b]quinazolin-13-imine)
Equus caballus
-
pH and temperature not specified in the publication
0.000076
(13Z,13'Z)-N,N'-heptane-1,7-diylbis(6,7,8,9,10,11-hexahydro-13H-azocino[2,1-b]quinazolin-13-imine)
Equus caballus
-
pH and temperature not specified in the publication
0.0045
(1alpha,3beta,22R)-stigmast-5-ene-1,3,22-triol
Equus caballus
-
-
0.083
(2,6,6-trimethylcyclohex-1-en-1-yl)methyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
Equus caballus
-
-
0.0127
(3E)-3-([4-[2-(diethylamino)ethoxy]phenyl]methylidene)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
Equus caballus
-
-
0.0071
(3E)-3-([4-[3-(diethylamino)propoxy]phenyl]methylidene)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
Equus caballus
-
-
0.003
(3E)-3-[(4-[2-[diethenyl(methylidene)-l5-azanyl]ethoxy]phenyl)methylidene]-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
Equus caballus
-
-
0.0017
(3E)-3-[(4-[3-[diethenyl(methylidene)-l5-azanyl]propoxy]phenyl)methylidene]-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
Equus caballus
-
-
0.000088
(9E,9'E)-N,N'-hexane-1,6-diylbis(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine)
Equus caballus
-
pH and temperature not specified in the publication
0.0000048
(9E,9'Z)-N,N'-heptane-1,7-diylbis(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine)
Equus caballus
-
pH and temperature not specified in the publication
0.0000514
(Z)-N1-methyl-N4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylidene)-N1-(3-((E)-8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-butane-1,4-diamine
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.000531
1,2-di(berberine-9-O-yl)ethane dibromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00023
1,2-dimethyl-beta-carbolin-2-ium iodide
Equus caballus
-
pH and temperature not specified in the publication
0.000231
1,3-di(berberine-9-O-yl)propane dibromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.0209
1-dehydrotestosterone
Equus caballus
-
-
0.00489
10-methoxy-9-(4-phenoxybutoxy)-5,6-dihydro[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.000027
10-[4-[(diethylamino)methyl]phenoxy]-N,N-diethyldecan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.000026
10-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropyldecan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.0615
11alpha,17beta-dihydroxyandrost-1,4-dien-3-one
Equus caballus
-
-
0.1647
11alpha-hydroxyandrost-1,4-dien-3,17-dione
Equus caballus
-
-
0.1413
11alpha-hydroxyandrost-4-en-3,17-dione
Equus caballus
-
-
0.284
11alpha-hydroxytestolactone
Equus caballus
-
-
0.089
11alpha-hydroxytestosterone
Equus caballus
-
-
0.047
15alpha,16alpha-epoxy-17-hydroxy-ent-kauran-19-oic acid
Equus caballus
-
-
0.025
16 alpha-hydroxy-17-isovaleroyloxy-ent-kauran-19-oic acid
Equus caballus
-
-
0.017
16alpha,17-dihydroxy-ent-kauran-19-oic acid
Equus caballus
-
-
0.019
17-hydroxy-ent-kaur-15-en-19-oic acid
Equus caballus
-
-
0.0959
17beta-hydroxy-5alpha-androstan-3,6-dione
Equus caballus
-
-
0.072
18-nor-ent-Kaur-16-ene-4 beta-ol
Equus caballus
-
-
0.0178
18-nor-ent-pimara-8(14),15-diene-4 beta-ol
Equus caballus
-
-
0.0001221
2-acetamido-N-(4-(8,9,10,11-tetrahydro-6H-azocino-[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,-11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)acetamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.000637
2-ethyl-1-methyl-beta-carbolin-2-ium iodide
Equus caballus
-
pH and temperature not specified in the publication
0.0235
2-[cyano(3-indolyl)methylene]-3-indolone
Equus caballus
-
pH 8.0, 25°C
0.0163
3'-hydroxyepiglucoisatisin
Equus caballus
-
pH 8.0, 25°C
0.000017
3,3'-[butane-1,4-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
Equus caballus
-
pH and temperature not specified in the publication
0.00014
3,3'-[butane-1,4-diylbis(oxy)]bis(7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine)
Equus caballus
-
pH and temperature not specified in the publication
0.000051
3,3'-[butane-1,4-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
Equus caballus
-
pH and temperature not specified in the publication
0.00092
3,3'-[dodecane-1,12-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
Equus caballus
-
pH and temperature not specified in the publication
0.000036
3,3'-[dodecane-1,12-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
Equus caballus
-
pH and temperature not specified in the publication
0.000014
3,3'-[hexane-1,6-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
Equus caballus
-
pH and temperature not specified in the publication
0.000027
3,3'-[hexane-1,6-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
Equus caballus
-
pH and temperature not specified in the publication
0.00068
3,3'-[octane-1,8-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
Equus caballus
-
pH and temperature not specified in the publication
0.00021
3,3'-[octane-1,8-diylbis(oxy)]bis(7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine)
Equus caballus
-
pH and temperature not specified in the publication
0.00011
3,3'-[octane-1,8-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
Equus caballus
-
pH and temperature not specified in the publication
0.000017
3,3'-[pentane-1,5-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
Equus caballus
-
pH and temperature not specified in the publication
0.000047
3,3'-[pentane-1,5-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
Equus caballus
-
pH and temperature not specified in the publication
0.00015
3,3'-[propane-1,3-diylbis(oxy)]bis(5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinoline)
Equus caballus
-
pH and temperature not specified in the publication
0.00016
3,3'-[propane-1,3-diylbis(oxy)]bis(7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium) diiodide
Equus caballus
-
pH and temperature not specified in the publication
0.02
3-(4-propoxybenzyl)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
Equus caballus
-
above
0.0083
3-(4-[2-[diethenyl(methylidene)-l5-azanyl]ethoxy]benzyl)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
Equus caballus
-
-
0.0057
3-(4-[3-[diethenyl(methylidene)-l5-azanyl]propoxy]benzyl)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
Equus caballus
-
-
0.0064
3-methoxy-7-methyl-5,8,9,13b-tetrahydro-6H-isoquinolino[1,2-a]isoquinolinium iodide
Equus caballus
-
pH and temperature not specified in the publication
0.0000081
3-methyl-N-(4-(8,9,10,11-tetrahydro-6H-azocino-[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,-10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)butanamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.02
3-[4-[3-(diethylamino)propoxy]benzyl]-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
Equus caballus
-
above
0.000003
4-methyl-N-(4-(8,9,10,11-tetrahydro-6H-azocino-[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,-10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)pentanamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.00274
4-[4-[(diethylamino)methyl]phenoxy]-N,N-diethylbutan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.01169
4-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropylbutan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.1
5'-O-Methyladenosine
Equus caballus
-
value above 0.1
0.0005
5,7,8,13-tetrahydroindolo [2',3':3,4]pyrido[2,1-b]quinazoline
Equus caballus
-
-
0.0044
5,8-dihydro-6H isoquino[1,2b]quinazoline
Equus caballus
-
-
0.00442
5-[4-[(diethylamino)methyl]phenoxy]-N,N-diethylpentan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.00178
5-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropylpentan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.0132
6-chloro-2-methyl-9H-beta-carbolin-2-ium iodide
Equus caballus
-
pH and temperature not specified in the publication
0.0012
6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium iodide
Equus caballus
-
pH and temperature not specified in the publication
0.00166
6-[4-[(diethylamino)methyl]phenoxy]-N,N-diethylhexan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.00134
6-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropylhexan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.094
7-oxo-ent-pimara-8(14),15-diene-19-oic acid
Equus caballus
-
-
0.000048
8-[4-[(diethylamino)methyl]phenoxy]-N,N-diethyloctan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.0000091
8-[4-[(diethylamino)methyl]phenoxy]-N,N-dipropyloctan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.0158
9-O-[(2-(3-methyl)pyridinium bromide)ethyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00282
9-O-[(2-pyridinium)bromide ethyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00168
9-O-[(3-o xo-3-p-chlorophenylamino)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00101
9-O-[(3-oxo-3-p-methoxyamino)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00553
9-O-[(3-oxo-3-p-nitrophenylamino)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00131
9-O-[(3-oxo-3-p-tolylamino)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00218
9-O-[(3-oxo-3-phenylamino)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.0133
9-O-[(3-pyridinium bromide)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00416
9-O-[3-(2-pyridinoxyl)butyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00111
9-O-[3-(3-methyl pyridinium bromide)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00544
9-O-[3-(4-bromo-phenoxyl)butyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00424
9-O-[3-(4-bromo-phenoxyl)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.0022
9-O-[3-(4-chloro-phenoxyl) butyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.0018
9-O-[3-(4-chloro-phenoxyl)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00286
9-O-[3-(4-methoxy-phenoxyl)-propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00229
9-O-[3-(4-methoxy-phenoxyl)butyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00181
9-O-[3-(4-methyl-phenoxyl) propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00205
9-O-[3-(4-nitro-phenoxyl)butyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00283
9-O-[3-(4-nitro-phenoxyl)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00217
9-O-[3-(N-methyl-phenylamino)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.0011
9-O-[3-(naphthalen-2-yloxy)butyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.0022
9-O-[3-(naphthalen-2-yloxy)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.000078
9-O-[3-(naphthalene-2-ylthio)butyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.000548
9-O-[3-(naphthalene-2-ylthio)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.00176
9-O-[3-(phenylamino)propyl]-berberine bromide
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.0106
abamectin
Equus caballus
-
pH 7.5, 37°C
0.1027
androst-1,4-dien-3,17-dione
Equus caballus
-
-
0.00155
androst-4-en-3,7-dione
Equus caballus
-
-
0.0655
atricarpan B
Equus caballus
-
-
0.0195
atricarpan C
Equus caballus
-
-
0.0305
atricarpan D
Equus caballus
-
-
0.083
bulbocapnine
Equus caballus
-
-
0.0011
buxoviricine
Equus caballus
-
-
0.052
corydine
Equus caballus
-
-
0.01393
Cycloartenol
Equus caballus
-
-
0.02239
ent-kaur-16-en-19-oic-acid
Equus caballus
-
-
0.00758
ent-pimar-15-en-8 alpha, 19-diol
Equus caballus
-
-
0.107
ent-pimara-8(14),15-diene-19-oic acid
Equus caballus
-
-
0.042
ent-pimara-8(14),15-diene-19-ol
Equus caballus
-
-
0.0197
epiglucoisatisin
Equus caballus
-
pH 8.0, 25°C
0.00796 - 0.0157
galanthamine
0.019
haloxyline A
Equus caballus
-
-
0.0147
haloxyline B
Equus caballus
-
-
0.09
Harmane
Equus caballus
-
pH and temperature not specified in the publication
0.02
hyrcanone
Equus caballus
-
-
0.0434
isatan A
Equus caballus
-
pH 8.0, 25°C
0.0476
isatan B
Equus caballus
-
pH 8.0, 25°C
0.0016
leufolin A
Equus caballus
-
-
0.0036
leufolin B
Equus caballus
-
-
0.000267
N,N-bis(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl) acetamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.0000727
N,N-bis(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)acetamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.000015
N,N-dibutyl-10-[4-[(diethylamino)methyl]phenoxy]decan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.00252
N,N-dibutyl-4-[4-[(diethylamino)methyl]phenoxy]butan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.0019
N,N-dibutyl-5-[4-[(diethylamino)methyl]phenoxy]pentan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.00023
N,N-dibutyl-6-[4-[(diethylamino)methyl]phenoxy]hexan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.000017
N,N-dibutyl-8-[4-[(diethylamino)methyl]phenoxy]octan-1-amine
Equus caballus
-
pH and temperature not specified in the publication
0.0000106
N-(4-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)butyl)-N-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl) methacrylamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.0000059
N-(4-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)butyl)-N-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl) propionamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.000004
N-(4-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)butyl)-N-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl)acetamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.0000431
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro--6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-acetamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.0000377
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-methacrylamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.0000129
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-pentanamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.0000255
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-pivalamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.0000463
N-(4-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)-propionamide
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.00019
N-ethyl-N-(4-[[10-(4-ethylpiperazin-1-yl)decyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.000033
N-ethyl-N-(4-[[10-(4-methylpiperazin-1-yl)decyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.000078
N-ethyl-N-(4-[[10-(piperidin-1-yl)decyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.000068
N-ethyl-N-(4-[[10-(pyrrolidin-1-yl)decyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00308
N-ethyl-N-(4-[[5-(4-ethylpiperazin-1-yl)pentyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00935
N-ethyl-N-(4-[[5-(4-methylpiperazin-1-yl)pentyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00067
N-ethyl-N-(4-[[5-(piperidin-1-yl)pentyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00154
N-ethyl-N-(4-[[5-(pyrrolidin-1-yl)pentyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.0022
N-ethyl-N-(4-[[6-(4-ethylpiperazin-1-yl)hexyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00376
N-ethyl-N-(4-[[6-(4-methylpiperazin-1-yl)hexyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00137
N-ethyl-N-(4-[[6-(piperidin-1-yl)hexyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00128
N-ethyl-N-(4-[[6-(pyrrolidin-1-yl)hexyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.000014
N-ethyl-N-(4-[[8-(4-ethylpiperazin-1-yl)octyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.000011
N-ethyl-N-(4-[[8-(4-methylpiperazin-1-yl)octyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.0000073
N-ethyl-N-(4-[[8-(piperidin-1-yl)octyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.000015
N-ethyl-N-(4-[[8-(pyrrolidin-1-yl)octyl]oxy]benzyl)ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.02027
N-ethyl-N-[4-[2-(4-methylpiperazin-1-yl)ethoxy]benzyl]ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.0101
N-ethyl-N-[4-[2-(piperidin-1-yl)ethoxy]benzyl]ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00973
N-ethyl-N-[4-[4-(4-methylpiperazin-1-yl)butoxy]benzyl]ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.00071
N-ethyl-N-[4-[4-(piperidin-1-yl)butoxy]benzyl]ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.0014
N-ethyl-N-[4-[4-(pyrrolidin-1-yl)butoxy]benzyl]ethanamine
Equus caballus
-
pH and temperature not specified in the publication
0.0005471
N1-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylidene)-N3-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl)-N3-methylpropane-1,3-diamine
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.0000813
N1-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylidene)-N4-(3-(2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-ylideneamino)propyl)-N4-methylbutane-1,4-diamine
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.000197
N1-methyl-N3-(8,9,10,11-tetrahydro-6H-azocino[2,1-b]quinazolin-13(7H)-ylidene)-N1-(3-(8,9,10,11-tetrahydro-6Hazocino[2,1-b]quinazolin-13(7H)-ylideneamino)propyl)propane-1,3-diamine
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.02
O-(4-bromo-2-[[3-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0202
O-(4-bromo-2-[[4-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0199
O-(4-chloro-2-[[3-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0156
O-(4-chloro-2-[[4-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.015
O-(5-chloro-2-[[3-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0183
O-(5-chloro-2-[[4-(trifluoromethyl)phenyl]carbamoyl]phenyl) O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0151
O-[2-[(3-bromophenyl)carbamoyl]-4-chlorophenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0149
O-[2-[(3-bromophenyl)carbamoyl]-5-chlorophenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0151
O-[2-[(4-bromophenyl)carbamoyl]-4-chlorophenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0164
O-[2-[(4-bromophenyl)carbamoyl]-5-chlorophenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0188
O-[4-bromo-2-[(3,4-dichlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.02
O-[4-bromo-2-[(3-bromophenyl)carbamoyl]phenyl] diethyl phosphate
Equus caballus
-
pH and temperature not specified in the publication
0.0139
O-[4-bromo-2-[(3-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0122
O-[4-bromo-2-[(3-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0189
O-[4-bromo-2-[(4-bromophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0135
O-[4-bromo-2-[(4-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0126
O-[4-bromo-2-[(4-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0174
O-[4-chloro-2-[(3,4-dichlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0148
O-[4-chloro-2-[(3-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0118
O-[4-chloro-2-[(3-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0127
O-[4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0149
O-[4-chloro-2-[(4-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0147
O-[5-chloro-2-[(3,4-dichlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0125
O-[5-chloro-2-[(3-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.00868
O-[5-chloro-2-[(3-fluorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.0138
O-[5-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.00867
O-[5-chloro-2-[(4-fluorophenyl)-carbamoyl]phenyl] O,O-diethyl phosphorothioate
Equus caballus
-
pH and temperature not specified in the publication
0.062
p-hydroxybenzoic acid
Equus caballus
-
-
0.0037
physostigmine
Equus caballus
-
pH and temperature not specified in the publication
0.01995
rivastigmine
Equus caballus
-
pH and temperature not specified in the publication
0.00125
salignarine-C
Equus caballus
-
-
0.0015
sarcovagenine-C
Equus caballus
-
-
0.0125
slavin A
Equus caballus
-
-
0.0655
slavin B
Equus caballus
-
-
0.0248
sulfoglucobrassicin
Equus caballus
-
pH 8.0, 25°C
0.0000064 - 0.0182
tacrine
0.1425
testolactone
Equus caballus
-
-
0.0535
testosterone
Equus caballus
-
-
0.205
vanilloloside
Equus caballus
-
-
additional information
additional information
Equus caballus
-
-
-
0.00744
Berberine
Equus caballus
pH 8.0, 22°C
0.00981
Berberine
Equus caballus
pH 8.0, 22°C
0.00796
galanthamine
Equus caballus
-
pH and temperature not specified in the publication
0.0084
galanthamine
Equus caballus
-
pH and temperature not specified in the publication
0.0085
galanthamine
Equus caballus
-
-
0.0085
galanthamine
Equus caballus
-
pH 8.0, 25°C
0.0157
galanthamine
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
0.0000064
tacrine
Equus caballus
-
in 100 mM potassium dihydrogen phosphate buffer, pH 8.0, at 25°C
0.00001
tacrine
Equus caballus
-
-
0.0182
tacrine
Equus caballus
-
in 0.1 M KH2PO4/K2HPO4 buffer (pH 8.0), at 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Main, A.R.; Tarkan, E.; Aull, J.L.; Soucie, W.G.
Purification of horse serum cholinesterase by preparative polyacrylamide gel electrophoresis
J. Biol. Chem.
247
566-571
1972
Equus caballus
brenda
Lee, J.C.; Harpst, J.A.
Physical properties and subunit structure of butyrylcholinesterase from horse serum
Biochemistry
12
1622-1630
1973
Equus caballus
brenda
Main, A.R.; Soucie, W.G.; Buxton, I.L.; Arinc, E.
The purification of cholinesterase from horse serum
Biochem. J.
143
733-744
1974
Equus caballus
brenda
Alsen, C.; Bertram, U.; Gersteuer, T.; Ohnesorge, F.K.
Studies on acetylcholinesterase and cholinesterase covalently bound to polymaleinic anhydride
Biochim. Biophys. Acta
377
297-302
1975
Equus caballus
brenda
Brown, S.S.; Kalow, W.; Pilz, W.; Whittaker, M.; Woronick, C.L.
The plasma cholinesterase: a new perspective
Adv. Clin. Chem.
22
1-123
1981
Canis lupus familiaris, Equus caballus, Homo sapiens, Mus musculus, Pleuronectes platessa, Pseudomonas aeruginosa, Rattus norvegicus, Sus scrofa
brenda
Kovacs, K.; Szajani, B.; Boross, L.
Preparation and properties of a novel immobilized cholinesterase
J. Appl. Biochem.
4
11-18
1982
Equus caballus
-
brenda
Jrv, J.; Speek, M.
Reversible inhibition of butyrylcholinesterase with aromatic hydrocarbons
Biochim. Biophys. Acta
706
174-178
1982
Equus caballus
brenda
Ralston, J.S.; Main, A.R.; Kilpatrick, B.F.; Chasson, A.L.
Use of procainamide gels in the purification of human and horse serum cholinesterases
Biochem. J.
211
243-250
1983
Equus caballus, Homo sapiens
brenda
Golicnik, M.; Sinko, G.; Simeon-Rudolf, V.; Grubic, Z.; Stojan, J.
Kinetic Model of ethopropazine Interaction with horse serum butyrylcholinesterase and its docking into the active site
Arch. Biochem. Biophys.
398
23-31
2002
Equus caballus
brenda
Wierdl, M.; Morton, C.L.; Danks, M.K.; Potter, P.M.
Isolation and characterization of a cDNA encoding a horse liver butyrylcholinesterase: evidence for CPT-11 drug activation
Biochem. Pharmacol.
59
773-781
2000
Equus caballus (Q9N1N9), Equus caballus
brenda
Saxena, A.; Fedorko, J.M.; Vinayaka, C.R.; Medhekar, R.; Radic, Z.; Taylor, P.; Lockridge, O.; Doctor, B.P.
Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases
Eur. J. Biochem.
270
4447-4458
2003
Equus caballus, Homo sapiens
brenda
Primozic, I.; Hrenar, T.; Tomic, S.; Meic, Z.
Stereoselective hydrolysis of quaternary quinuclidinium benzoates catalyzed by butyrylcholinesterase
Eur. J. Org. Chem.
2003
295-301
2003
Equus caballus
-
brenda
Zhukovskii, Y.G.
On establishment of individuality of the cholinesterase enzyme in the studied preparation
J. Evol. Biochem. Physiol.
39
281-290
2003
Equus caballus
-
brenda
Zhan, C.G.; Gao, D.
Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine
Biophys. J.
89
3863-3872
2005
Equus caballus
brenda
Lin, G.; Lee, Y.R.; Liu, Y.C.; Wu, Y.G.
Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase
Chem. Res. Toxicol.
18
1124-1131
2005
Equus caballus
brenda
Rozengart, E.V.; Basova, N.E.
Elementorganic bisonium reversible inhibitors of different cholinesterases
Dokl. Biochem. Biophys.
395
99-103
2004
Equus caballus, Berryteuthis magister
brenda
Chiou, S.Y.; Lai, G.W.; Tsai, Y.H.; Lee, Y.R.; Lin, L.Y.; Lin, G.L.
Kinetics and mechanisms of acetylcholinesterase and butyrylcholinesterase inhibition by cardiovascular drugs and benzodiazepines
J. Chin. Chem. Soc.
52
843-848
2005
Equus caballus
-
brenda
Bajgar, J.; Bartosova, L.; Kuca, K.; Jun, D.; Fusek, J.
Changes of cholinesterase activities in the rat blood and brain after sarin intoxication pretreated with butyrylcholinesterase
Drug Chem. Toxicol.
30
351-359
2007
Equus caballus, Rattus norvegicus
brenda
Chiou, S.Y.; Wu, Y.G.; Lin, Y.F.; Lin, L.Y.; Lin, G.
Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate
J. Biochem. Mol. Toxicol.
21
24-31
2007
Equus caballus
brenda
Rozengart, E.V.; Basova, N.E.; Suvorov, A.A.
How thionphosphonates inhibit activity of different cholinesterases
J. Evol. Biochem. Physiol.
43
164-173
2007
Equus caballus, Berryteuthis magister
-
brenda
Zdrazilova, P.; Stepankova, S.; Komersova, A.; Vranova, M.; Komers, K.; Cegan, A.
Kinetics of 13 new cholinesterase inhibitors
Z. Naturforsch. C
61
611-617
2006
Equus caballus
brenda
Chiou, S.Y.; Wu, Y.G.; Lin, G.
Activation mechanisms of butyrylcholinesterase by 2,4,6-trinitrotoluene, 3,3-dimethylbutyl-N-n-butylcarbamate, and 2-trimethylsilyl-ethyl-N-n-butylcarbamate
Appl. Biochem. Biotechnol.
150
337-344
2008
Equus caballus
brenda
Yuecel, Y.Y.; Tacal, O.; Ozer, I.
Comparative effects of cationic triarylmethane, phenoxazine and phenothiazine dyes on horse serum butyrylcholinesterase
Arch. Biochem. Biophys.
478
201-205
2008
Equus caballus
brenda
Pan, L.; Tan, J.H.; Hou, J.Q.; Huang, S.L.; Gu, L.Q.; Huang, Z.S.
Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors
Bioorg. Med. Chem. Lett.
18
3790-3793
2008
Equus caballus
brenda
Loizzo, M.R.; Tundis, R.; Menichini, F.; Menichini, F.
Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update
Curr. Med. Chem.
15
1209-1228
2008
Equus caballus, Homo sapiens
brenda
Ahmad, I.; Fatima, I.
Butyrylcholinesterase, lipoxygenase inhibiting and antifungal alkaloids from Isatis tinctoria
J. Enzyme Inhib. Med. Chem.
23
313-316
2008
Equus caballus
brenda
Al-Aboudi, A.; Odeh, H.; Khalid, A.; Naz, Q.; Choudhary, M.I.
Butyrylcholinesterase inhibitory activity of testosterone and some of its metabolites
J. Enzyme Inhib. Med. Chem.
24
553-558
2008
Equus caballus
brenda
Rozengart, E.V.; Basova, N.E.
Thiosubstrates of cholinesterases of different origin
J. Evol. Biochem. Physiol.
44
12-23
2008
Columba livia, Oryctolagus cuniculus, Drosophila melanogaster, Equus caballus, Helicoverpa armigera, Locusta migratoria migratorioides, Musca domestica, Nippostrongylus brasiliensis, no activity in Bos taurus, no activity in Zea mays, Todarodes pacificus, Triatoma infestans, Schizaphis graminum, Berryteuthis magister, Acyrthosiphon pisum, Neogale vison, Delia floralis, Delia antiqua, Coccinella septempunctata, Berryteuthis anonychus, Gonatus kamtschaticus, Eogonatus tinro, Gonatopsis borealis, no activity in Solanum melongena, no activity in Tetranychus urticae, no activity in Acheta domesticus, no activity in Triatoma infestans, no activity in Branchiostoma floridae, no activity in Electrophorus electricus, no activity in Torpedo marmorata
-
brenda
Orhan, I.; Tosun, F.; Sener, B.
Coumarin, anthroquinone and stilbene derivatives with anticholinesterase activity
Z. Naturforsch. C
63
366-370
2008
Equus caballus
brenda
Orhan, I.; Kartal, M.; Kan, Y.; Sener, B.
Activity of essential oils and individual components against acetyl- and butyrylcholinesterase
Z. Naturforsch. C
63
547-553
2008
Equus caballus
brenda
Debord, J.; Harel, M.; Verneuil, B.; Bollinger, J.; Dantoine, T.
Microcalorimetric study of the inhibition of butyrylcholinesterase by paraoxon
Anal. Biochem.
389
97-101
2009
Equus caballus
brenda
Jung, H.A.; Lee, E.J.; Kim, J.S.; Kang, S.S.; Lee, J.H.; Min, B.S.; Choi, J.S.
Cholinesterase and BACE1 inhibitory diterpenoids from Aralia cordata
Arch. Pharm. Res.
32
1399-1408
2009
Equus caballus
brenda
Jung, H.A.; Jung, Y.J.; Hyun, S.K.; Min, B.S.; Kim, D.W.; Jung, J.H.; Choi, J.S.
Selective cholinesterase inhibitory activities of a new monoterpene diglycoside and other constituents from Nelumbo nucifera stamens
Biol. Pharm. Bull.
33
267-272
2010
Equus caballus
brenda
Menichini, F.; Tundis, R.; Loizzo, M.; Bonesi, M.; Marrelli, M.; Statti, G.; Menichini, F.; Conforti, F.
Acetylcholinesterase and butyrylcholinesterase inhibition of ethanolic extract and monoterpenes from Pimpinella anisoides V Brig. (Apiaceae)
Fitoterapia
80
297-300
2009
Equus caballus
brenda
Orhan, I.; Senol, F.; Kartal, M.; Dvorska, M.; Zemlicka, M.; Smejkal, K.; Mokry, P.
Cholinesterase inhibitory effects of the extracts and compounds of Maclura pomifera (Rafin.) Schneider
Food Chem. Toxicol.
47
1747-1751
2009
Equus caballus
brenda
Schulze, M.; Siol, O.; Decker, M.; Lehmann, J.
Bivalent 5,8,9,13b-tetrahydro-6H-isoquino[1,2-a]isoquinolines and -isoquinolinium salts: Novel heterocyclic templates for butyrylcholinesterase inhibitors
Bioorg. Med. Chem. Lett.
20
2946-2949
2010
Equus caballus
brenda
Yu, L.; Cao, R.; Yi, W.; Yan, Q.; Chen, Z.; Ma, L.; Peng, W.; Song, H.
Synthesis of 4-[(diethylamino)methyl]-phenol derivatives as novel cholinesterase inhibitors with selectivity towards butyrylcholinesterase
Bioorg. Med. Chem. Lett.
20
3254-3258
2010
Equus caballus
brenda
Huang, L.; Luo, Z.; He, F.; Lu, J.; Li, X.
Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase
Bioorg. Med. Chem.
18
4475-4484
2010
Equus caballus
brenda
Chen, X.; Tikhonova, I.G.; Decker, M.
Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors
Bioorg. Med. Chem.
19
1222-1235
2011
Equus caballus
brenda
Moralev, S.N.; Tikhonov, D.B.
Investigation of structure-activity relationships in organophosphates-cholinesterase interaction using docking analysis
Chem. Biol. Interact.
187
153-156
2010
Equus caballus
brenda
Rozengart, E.; Basova, N.
Activatory effect of substrates on the cholinesterase catalysis
Dokl. Biochem. Biophys.
430
7-10
2010
Equus caballus
brenda
Basova, N.; Rozengart, E.
How various substrates activate the process of enzymatic hydrolysis by different cholinesterases
J. Evol. Biochem. Physiol.
46
580-584
2010
Equus caballus, Todarodes pacificus
-
brenda
Stojan, J.
The significance of low substrate concentration measurements for mechanistic interpretation in cholinesterases
Chem. Biol. Interact.
203
44-50
2013
Equus caballus
brenda
Vinsova, J.; Kratky, M.; Komloova, M.; Dadapeer, E.; Stepankova, S.; Vorcakova, K.; Stolarikova, J.
Diethyl 2-(phenylcarbamoyl)phenyl phosphorothioates: synthesis, antimycobacterial activity and cholinesterase inhibition
Molecules
19
7152-7168
2014
Equus caballus
brenda
Torres, J.M.; Lira, A.F.; Silva, D.R.; Guzzo, L.M.; SantAnna, C.M.; Kuemmerle, A.E.; Rumjanek, V.M.
Structural insights into cholinesterases inhibition by harmane beta-carbolinium derivatives: A kinetics-molecular modeling approach
Phytochemistry
81
24-30
2012
Equus caballus
brenda
Ali, M.Y.; Seong, S.H.; Jung, H.A.; Jannat, S.; Choi, J.S.
Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1
Arch. Pharm. Res.
41
753-764
2018
Equus caballus (P81908)
brenda
Fogle, E.J.; Marlier, J.F.; Stillman, A.; Gao, X.; Rao, Y.; Robins, L.I.
An investigation into the butyrylcholinesterase-catalyzed hydrolysis of formylthiocholine using heavy atom kinetic isotope effects
Bioorg. Chem.
65
57-60
2016
Equus caballus (P81908)
brenda
Sultana, N.; Sarfraz, M.; Tanoli, S.T.; Akram, M.S.; Sadiq, A.; Rashid, U.; Tariq, M.I.
Synthesis, crystal structure determination, biological screening and docking studies of N1-substituted derivatives of 2,3-dihydroquinazolin-4(1H)-one as inhibitors of cholinesterases
Bioorg. Chem.
72
256-267
2017
Equus caballus (P81908)
brenda
Wieckowska, A.; Wieckowski, K.; Bajda, M.; Brus, B.; Salat, K.; Czerwinska, P.; Gobec, S.; Filipek, B.; Malawska, B.
Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with beta-amyloid anti-aggregation properties and beneficial effects on memory in vivo
Bioorg. Med. Chem.
23
2445-2457
2015
Equus caballus (P81908)
brenda
Liu, Z.; Fang, L.; Zhang, H.; Gou, S.; Chen, L.
Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property
Bioorg. Med. Chem.
25
2387-2398
2017
Equus caballus (P81908)
brenda
Mohammed, A.; Sneathen, J.; Frojen, S.G.; Kuo, L.; Dupureur, C.M.
Stereospecific cholinesterase inhibition by O,S-diethylphenylphosphonothioate
Bioorg. Med. Chem.
25
3053-3058
2017
Equus caballus (P81908), Equus caballus
brenda
Nakayama, K.; Schwans, J.P.; Sorin, E.J.; Tran, T.; Gonzalez, J.; Arteaga, E.; McCoy, S.; Alvarado, W.
Synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors
Bioorg. Med. Chem.
25
3171-3181
2017
Equus caballus (P81908)
brenda
Begum, S.; Nizami, S.S.; Mahmood, U.; Masood, S.; Iftikhar, S.; Saied, S.
In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as butyrylcholinesterase (BChE) inhibitors
Comput. Biol. Chem.
74
212-217
2018
Equus caballus (P81908)
brenda
Terali, K.; Dalmizrak, O.; Hoti, Q.; Ozer, N.
Evaluation of the inhibitory effect of abamectin on mammalian butyrylcholinesterase enzyme kinetic and molecular docking studies
J. Environ. Sci. Health B
8
1-6
2018
Equus caballus
brenda
Ali, M.Y.; Seong, S.H.; Reddy, M.R.; Seo, S.Y.; Choi, J.S.; Jung, H.A.
Kinetics and molecular docking studies of 6-formyl umbelliferone isolated from Angelica decursiva as an inhibitor of cholinesterase and BACE1
Molecules
22
1604-1616
2017
Equus caballus (P81908)
brenda